DOCSLIB.ORG

INFOPAN-N-97.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
INFOPAN-N-97.Pdf ÍNDICE 1. Noticias destacadas 2. Aperturas y restricciones 3. Educación 4. Situación Epidemiológica 5. Vacunas, tratamientos y desarrollos tecnológicos 6. Sistema de salud 7. Turismo y recreación 8. Relaciones internacionales 9. Salud mental Entre los diferentes recursos que el Ministerio de Salud ha desarrollado durante la Pandemia el Boletín periódico INFOPAN surgió frente a la necesidad de sumar a la Sala de Situación COVID 19 de la Provincia de Buenos Aires una herramienta de navegación a tiempo real que sistematiza las principales noticias sobre esta temible enfermedad que provienen de distintos países y regiones del planeta. Es precisamente el carácter pandémico de esta enfermedad el que explica el carácter estratégico de monitorear su paso e impacto por diferentes latitudes, la organización y las respuestas alternativas de los servicios de salud, los desarrollos científico- tecnológicos y las diversas políticas públicas que se aplican con mayor o menor impacto. Luego de varios meses de sistematización, la evaluación de la calidad y de la pertinencia del material producido nos abrió el interrogante sobre si no podría resultar también de utilidad para otras audiencias como formadores de opinión, decisores técnicopolíticos, dirigentes gremiales, políticos o estudiantiles, comunicadores sociales, o simplemente ciudadanos y ciudadanas interesadas. Invitamos a su lectura, su difusión y a comunicarnos sus sugerencias para mejorar su alcance y aplicación. 1. NOTICIAS DESTACADAS BRASIL: El país llegó al primer año de la pandemia con más de 250 mil decesos Se realizaron diversas protestas solicitando el juicio político contra el presidente Jair Bolsonaro por su gestión frente al coronavirus. https://www.telesurtv.net/news/brasil-sobrepasa-doscientos-cincuenta-mil- decesos-covid-20210226-0005.html El consejo de Fauci: hay que ponerse la vacuna que esté disponible, sin importar la que sea. El principal experto en enfermedades infecciosas de Estados Unidos, el doctor Anthony Fauci, recomendó el jueves a la gente que se aplique la vacuna contra el coronavirus que esté disponible, sin importar la que sea. En declaraciones al canal NBC, Fauci indicó que la aprobación de una tercera vacuna en el país “no es sino buenas noticias” y que ayudará a controlar la pandemia. Los reguladores estadounidenses anunciaron el miércoles que la vacuna de Johnson & Johnson es eficaz contra el virus y que requiere de una sola inyección. Su aprobación luce inminente. https://www.telemundodallas.com/noticias/salud/coronavirus/coronavirus-en- estados-unidos/el-consejo-de-fauci-hay-que-ponerse-la-vacuna-que-este- disponible-sin-importar-la-que-sea/2146761/ ISRAEL: Se llegó al 50% de la población vacunada. Israel ha administrado al menos una dosis de la vacuna COVID-19 al 50 por ciento de su población de 9,3 millones, dijo el viernes la ministra de Salud, Yuli Edelstein. Edelstein dijo que el 35 por ciento de la población de Israel había recibido ambas dosis de la vacuna Pfizer, lo que los puso en camino para recibir el llamado "Pase Verde" con acceso a sitios de ocio que el país ha ido reabriendo gradualmente. https://arab.news/weeyq RUSIA: Anunciaron que en marzo “sale al mundo” Sputnik Light, su vacuna contra el coronavirus de una sola dosis. El Fondo de Inversiones Directas de Rusia inició los trámites para registrar el desarrollo. Según las autoridades, el inmunizaste está dirigido al mercado exterior https://www.infobae.com/america/ciencia-america/2021/02/28/rusia-anuncio-que- en-marzo-sale-al-mundo-sputnik-light-su-vacuna-contra-el-coronavirus-de-una- sola-dosis/ 2. APERTURAS Y RESTRICCIONES AMÉRICA LATINA PERÚ: Anuncian la flexibilización de la cuarentena La jefa del gabinete, Violeta Bermúdez, indicó que la medida estará vigente durante dos semanas a partir del lunes 1° de marzo. La funcionaria indicó que la reducción de limitaciones obedece a una desaceleración en el incremento de contagios en la segunda ola de la pandemia y una reducción del número diario de muertes por la enfermedad. https://www.telesurtv.net/news/peru-anuncia-levantamiento-cuarentena-covid- 20210224-0036.html AMÉRICA DEL NORTE CANADÁ: Nuevas medidas de COVID-19 entran en vigencia en nueve regiones de Ontario, dos pasan al cierre. Hoy en día entraron en vigor nuevas medidas de salud pública destinadas a limitar la propagación del COVID-19 en nueve regiones de Ontario, incluidas dos que se dirigen al cierre debido al aumento de los casos. Las unidades de salud de Thunder Bay y Simcoe-Muskoka han visto un aumento de las infecciones en los últimos días, impulsadas en parte por la transmisión de variantes más infecciosas del virus. La provincia activó lo que describe como un "descanso de emergencia" para esos distritos, y los trasladó al nivel gris del plan de respuesta a una pandemia codificado por colores de Ontario. https://toronto.ctvnews.ca/new-covid-19-measures-take-effect-in-nine-ontario- regions-two-move-into-lockdown-1.5328278 EUROPA ESPAÑA: Valencia decide esta semana si suspende las vacaciones escolares en Fallas por el coronavirus. El Ayuntamiento de Valencia convocará esta semana una reunión extraordinaria del consejo escolar municipal para estudiar la petición de la Generalitat para que se declaren lectivos los días 16, 17 y 18 de marzo, que en el calendario de este curso figuran como festivos. El Ejecutivo autonómico cree que, tras la suspensión de las Fallas por la pandemia del coronavirus, el escenario ideal sería modificar la planificación escolar. https://www.abc.es/espana/comunidad-valenciana/abci-valencia-decide-esta- semana-si-suspende-vacaciones-escolares-fallas-coronavirus- 202103010926_noticia.html ESPAÑA: Comienza hoy la prudente desescalada en la Comunidad Valenciana. Tras semanas de semiconfinamiento, hoy entra en vigor el nuevo decreto de la Generalitat Valenciana que abre la mano a las duras restricciones que han permitido reducir notablemente el número de contagios, ingresos y muertos por covid. Las nuevas normas fueron acordadas el pasado jueves en la reunión de la comisión Interdepartamental y se mantendrán, en principio, durante dos semanas. Se reabren con muchas restricciones las terrazas, se amplía el horario del comercio y los aforos, se permite el deporte al aire libre y se levanta el cierre perimetral de las grandes ciudades. https://www.lavanguardia.com/local/valencia/20210228/6261327/comienza-hoy- prudente-desescalada-valenciana-covid.html FRANCIA: Macron pide "retener" otras "4 a 6 semanas." El jefe de Estado pidió el lunes a los franceses que "esperen" unas semanas más antes de que se considere la relajación de las restricciones sanitarias. https://www.lepoint.fr/politique/coronavirus-macron-demande-de-tenir-encore-4- a-6-semaines-01-03-2021-2415851_20.php FRANCIA: París y la región de Île-de-France se preparan para tomar nuevas medidas restrictivas. La alcaldesa de París, Anne Hidalgo, y la presidenta de la región, Valérie Pécresse, se reunirán con las autoridades sanitarias y de la prefectura el lunes durante reuniones separadas. Mientras tanto, el primer ministro Jean Castex pidió el sábado el fortalecimiento de los controles mientras un clima templado sacó a los franceses que pueden, incluidos muchos parisinos en los parques y en los muelles del Sena. Los ocho departamentos de Ile-de-France están todos bajo " vigilancia reforzada ", probablemente sujetos a medidas de contención local a partir del fin de semana del 6 de marzo, si la situación continúa desarrollándose. https://www.lefigaro.fr/actualite-france/covid-19-paris-et-la-region-ile-de-france- se-preparent-a-prendre-de-nouvelles-mesures-restrictives-20210228 ITALIA: Nuevo Decreto que llega el martes con las reglas anti-covid válidas hasta Semana Santa. Luz verde de las Regiones al texto que estará en vigor durante un mes: del viernes 6 de marzo al 6 de abril La firma de Draghi entre el lunes 1 de marzo y el martes 2. El nuevo Decreto introduce prohibiciones y restricciones que seguirán vigentes también para Pascua y el Lunes de Pascua (el segundo de la era Covid). La reapertura está prevista, aunque no de forma inmediata: a partir del 27 de marzo se reabrirán los cines y teatros, cumpliendo con los protocolos específicos, mientras que será posible ir al museo incluso los fines de semana. Aquí tienes una guía de las reglas con las novedades que tendrás que seguir. https://www.ilsole24ore.com/art/nuovo-Decreto-arrivo-entro-martedi-le-regole-anti- covid-valide-fino-pasqua-ADGrvrMB SUIZA: relajan las restricciones a partir del lunes. Ante la mejora de la situación sanitaria, el Consejo Federal Suizo decide reabrir tiendas, museos y determinadas instalaciones deportivas a partir del 1 de marzo. Si la situación continúa mejorando, otras restricciones podrían desaparecer en Suiza: reanudación de las actividades deportivas de interior, reapertura de restaurantes y regreso de la enseñanza presencial en las escuelas superiores. Pero esto será si y solo si se cumplen ciertos criterios, como una tasa de incidencia estable que no supere la del 1 de marzo, o si hay menos de 250 personas en cuidados intensivos por covid por ejemplo. https://www.francebleu.fr/infos/societe/coronavirus-la-suisse-assouplit-ses-restrictions-a- partir-de-lundi-1614517024 ASIA Y MEDIO ORIENTE OMÁN: Amplían las medidas de seguridad del COVID-19, cierra parques, playas y áreas de ocio de forma indefinida. El Comité Supremo de Omán que supervisa la respuesta al coronavirus del país ha extendido indefinidamente el cierre de playas, parques públicos y espacios de ocio para frenar la propagación de la enfermedad altamente contagiosa. https://arab.news/ywfp5 JORDANIA: Limitan la cantidad de trabajadores en oficinas gubernamentales. El primer ministro de Jordania ordenó a todos los ministerios, el gobierno y las instituciones públicas que operaran al 30 por ciento de su capacidad únicamente, informó la agencia estatal de noticias Petra. https://arab.news/4nusd 3. EDUCACIÓN AMÉRICA LATINA AMÉRICA LATINA: La región retorna a las clases presenciales Chile, Uruguay y Argentina dan reapertura a los colegios en medio de preocupación social por el regreso a clases presenciales.
Load more

Recommended publications
  • Cuba: One Year Into the Pandemic
    BULLETIN OF PAHO/WHO IN CUBA Vol. 25 No.1 JANUARY-MARCH 2021 CUBA: ONE YEAR INTO THE PANDEMIC 04 43 46 50 OUR NEWS: NOTEWORTHY: OVER A STORY A CUP OF TO TELL: Interview Benefits with Cuba's of a Cúrcumal onga COFFEE Dr. Ricardo Minister pdroject uring WITH… Pereda González: of Public Health, thep andemic Coordinator of Dr. José Angel Concepción the COVID-19 Clinical Portal Miranda Campa Experts Commission Huergo Pathways to Health is a bulletin prepared by the office of the Pan American Health Organization/World Health Organization EDITORIAL (PAHO/WHO) in Cuba. Its main aim is to share the most important aspects of the On March 11, 2020, the Director-General of the World Health Representation's technical cooperation with Organization (WHO) declared the novel coronavirus a pandemic, the country's Ministry of Public Health which at the time already affected 114 nations. Coincidentally, (MINSAP) and other institutions. that same day, the Pedro Kourí Tropical Medicine Institute (IPK) in Havana confirmed the first COVID-19 cases in Cuba. At the one-year anniversary of the pandemic in Cuba, this issue is dedicated to One year into the pandemic, more than 115 million cases and close to 2.6 million deaths have been reported from the disease systematically review key aspects of the worldwide. About half of both these cases and deaths have been national response over the last months. In registered in the Americas, with results differing according to how particular, it includes an interview with the well the response has been organized, how robust the healthcare Minister of Public Health, Dr.
    [Show full text]
  • Microsoft Outlook
    Morris, Max From: Morris, Max Sent: Monday, March 22, 2021 11:38 PM To: Morris, Max Subject: 03/22/2021 Coronavirus Daily Recap This email is provided for informational, non-commercial purposes only. Use or reliance on the information contained in this email is at your sole risk. This email is not provided by or affiliated in any way with Ally Financial Inc. These updates are being shared to multiple organizations, individuals and lists who/which are bcc’d. Best effort we are sending Daily updates during the business week, typically in the evening, a Weekend Recap on Monday mornings, and any significant breaking news events provided anytime. Please note some numbers included in the Statistics and news stories come from various sources and so can vary as they are constantly changing and not reported at the same time. All communications are TLP GREEN and can be shared freely. Know someone who might want to be added to our Updates? Of course ask them first, and then have them send us an email to [email protected]. Live the message, share the message: Be safe – Stay home and limit travel as much as possible, self-quarantine if you or any members of your family are or may be sick, if you go out wear your mask – the right way, ensure safe social distancing, and practice good hygiene – wash your hands, avoid touching your face, and sanitize used items and surfaces. Need to find a vaccine? Here are a few good sites and resources we have come across that may help: CDC Vaccine Finder – https://vaccinefinder.org/ [Free government website where users can search for pharmacies and providers that offer vaccinations, currently limited number of states but expanding] Dr.
    [Show full text]
  • COVID-19 Vaccination Programme: Information for Healthcare Practitioners
    COVID-19 vaccination programme Information for healthcare practitioners Republished 6 August 2021 Version 3.10 1 COVID-19 vaccination programme: Information for healthcare practitioners Document information This document was originally published provisionally, ahead of authorisation of any COVID-19 vaccine in the UK, to provide information to those involved in the COVID-19 national vaccination programme before it began in December 2020. Following authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency being given to the COVID-19 Vaccine Pfizer BioNTech on 2 December 2020, the COVID-19 Vaccine AstraZeneca on 30 December 2020 and the COVID-19 Vaccine Moderna on 8 January 2021, this document has been updated to provide specific information about the storage and preparation of these vaccines. Information about any other COVID-19 vaccines which are given regulatory approval will be added when this occurs. The information in this document was correct at time of publication. As COVID-19 is an evolving disease, much is still being learned about both the disease and the vaccines which have been developed to prevent it. For this reason, some information may change. Updates will be made to this document as new information becomes available. Please use the online version to ensure you are accessing the latest version. 2 COVID-19 vaccination programme: Information for healthcare practitioners Document revision information Version Details Date number 1.0 Document created 27 November 2020 2.0 Vaccine specific information about the COVID-19 mRNA 4 Vaccine BNT162b2 (Pfizer BioNTech) added December 2020 2.1 1.
    [Show full text]
  • National Emergency Management Organisation (Nemo) Ministry of National Security St
    NATIONAL EMERGENCY MANAGEMENT ORGANISATION (NEMO) MINISTRY OF NATIONAL SECURITY ST. VINCENT AND THE GRENADINES WEST INDIES Tel: 784-456-2975, Fax: 784-457-1691, Email: [email protected] or [email protected] ______________________________________________________________________________ ___________________________________________________________________________________________________________________ HEALTH SERVICES SUBCOMMITTEE PROTOCOL FOR THE ENTRY OF FULLY VACCINATED TRAVELLERS TO ST. VINCENT AND THE GRENADINES – revised 10/08/2021 AIM: The safe entry of travellers to St. Vincent and the Grenadines in a manner that reduces the risk of the importation and subsequent transmission of COVID-19 in St. Vincent and the Grenadines. OBJECTIVES: 1. To establish the risk of the arriving traveller introducing new COVID-19 cases to SVG; 2. To minimize exposure of residents of SVG to new COVID-19 cases; 3. Early identification of potential exposure to COVID-19 and 4. Early containment of new COVID-19 cases. ESTABLISH RISK OF ARRIVING TRAVELLER: The arriving traveller will: 1. Complete the Pre-Arrival Form available at health.gov.vc And the Port Health Officer will: 1. Review Port Health form for each arriving passenger. 1 PHASED PROCESS OF ENTRY OF FULLY VACCINATED TRAVELERS TO ST. VINCENT AND THE GRENADINES: TESTING & QUARANTINE: PHASE #16 - Commencing Wednesday, August 11, 2021: 1. Where ‘Fully Vaccinated Travelers’ are those persons who: a. Have completed a vaccination regimen with one of the following COVID-19 vaccines recognized by the Ministry of Health, Wellness and the Environment of St Vincent and the Grenadines: i. AstraZeneca – Oxford AstraZeneca (Vaxzevria), COVISHIELD, AstraZeneca COVID-19 vaccine by SK Bioscience; ii. Pfizer-BioNTech COVID-19 vaccine; iii. Moderna COVID-19 vaccine; iv.
    [Show full text]
  • Revision Rápida
    REVISION RÁPIDA EVALUACIÓN DE LAS CARACTERÍSTICAS DE ALMACENAMIENTO, TRANSPORTE Y DISTRIBUCIÓN DE LAS VACUNAS COVID-19 EN ESTUDIO, Y LAS CARACTERÍSTICAS CLÍNICAS DE LA POBLACIÓN CANDIDATA A VACUNACIÓN Noviembre de 2020 El Instituto de Evaluación Tecnológica en Salud – IETS, es una corporación sin ánimo de lucro, de participación mixta y de carácter privado, con patrimonio propio, creado según lo estipulado en la Ley 1438 de 2011. Su misión es contribuir al desarrollo de mejores políticas públicas y prácticas asistenciales en salud, mediante la producción de información basada en evidencia, a través de la evaluación de tecnologías en salud y guías de práctica clínica, con rigor técnico, independencia y participación. Sus miembros son el Ministerio de Salud y Protección Social – MinSalud, el Departamento Administrativo de Ciencia, Tecnología e Innovación – Colciencias, el Instituto Nacional de Vigilancia de Medicamentos y Alimentos – INVIMA, el Instituto Nacional de Salud – INS, la Asociación Colombiana de Facultades de Medicina – ASCOFAME y la Asociación Colombiana de Sociedades Científicas – ACSC. Autores Lucas López Quiceno. Médico y cirujano, Especialista en Epidemiología, Magister en Epidemiología, Magíster en economía de la salud (c). Instituto de Evaluación Tecnológica en Salud - IETS. Jhyld Carolaind Camacho Barbosa, Nutricionista y Dietista, Magister en Epidemiología. Instituto de Evaluación Tecnológica en Salud - IETS. Kelly Estrada-Orozco. Médica, Magister en Epidemiología Clínica, Magister en Neurociencia. Doctorado en Salud Pública (actual). Doctorado en Epidemiología Clínica (actual). Instituto de Evaluación Tecnológica en Salud - IETS. Revisores Cortes-Muñoz, Ani Julieth. Bacterióloga y laboratorista clínica. MSc. Epidemiología. Instituto de Evaluación Tecnológica en salud - IETS. Ospina-Lizarazo, Nathalie. Nutricionista Dietista. MSc. Epidemiología Clínica. Instituto de Evaluación Tecnológica en salud - IETS.
    [Show full text]
  • COVID Vaccine Quick Reference Chart for Timeline
    Pfizer-BioNTech Moderna Johnson & Johnson Novavax Oxford-AstraZeneca Sputnik V CureVac Sinopharm's BBIBP-CorV MOA mRNA vaccine mRNA vaccine Adenovirus vector vaccine Protein-based vaccine Adenovirus vector vaccine Adenovirus vector vaccine mRNA vaccine Inactivated virus Dosing 2 doses, 21 days apart 2 doses, 28 days apart 1 dose 2 doses, one month apart 2 doses, three months apart Sputnik Light requires one dose. 2 doses, four weeks apart 2 doses, three weeks apart Schedule The vaccine has been In a press release, the Gamaleya National D shown to be 89.3% effective Center of Epidemiology and Microbiology in in large-scale UK trials. Moscow claimed a large-scale Russian e 72% in the U.S. and 66% globally 76% in a U.S. study against Significantly, it is the first study saw 92% efficacy for its vaccine. t against moderate-to-severe symptomatic COVID-19; 100% 95% at least 7 days after 94.1% at least 14 days jab shown to be effective However, other scientists have voiced Efficacy results are presumed to 78% according to the World Health Efficacy disease; 85% effective against effective severe disease; 85% a dose 2 after dose 2 against the new UK variant concerns this claim is based on too few be released in May 2021. Organization severe disease, 28 days after a efficacy against symptomatic of COVID-19 in such a trial. cases. Although the vaccine was trialled on i single dose. COVID-19 in those 65+ 96% against original 18,000 people, the efficacy claim has been l coronavirus, 86% against B.
    [Show full text]
  • Comparative Characteristics of the Main Coronavirus Vaccines
    Acta Scientific MICROBIOLOGY (ISSN: 2581-3226) Volume 4 Issue 9 September 2021 Editorial Comparative Characteristics of the Main Coronavirus Vaccines Pavel F Zabrodskii* Received: June 23, 2021 Saratov Medical University "REAVIZ", Saratov, Russian Federation Published: August 01, 2021 *Corresponding Author: Pavel F Zabrodskii, Saratov Medical University "REAVIZ", © All rights are reserved by Pavel F Saratov, Russian Federation. Zabrodskii. Since the beginning of the epidemic, vaccine development has been a priority for all developed countries. According to WHO (26 adenovirus rather than human adenovirus should reduce the risk virus. The fact that the vaccine was developed using chimpanzee January 2021), more than 60 vaccines worldwide are already in of allergic reactions and severe side-effects. However, the disadvan- clinical trials. More than 170 are being tested on animals. There tage of this product, as with all vector vaccines, is that the technol- ogy itself is new and has not previously been used in health care. One of the pluses for vector drug manufacturers is their speed of are 22 vaccines that have made it through the final phase of testing. creation. The vaccine is registered for use in the European Union. It The vaccine, developed by US company “Pfizer” and its German is licensed for emergency use in another 20 countries. clinical trials ended on 9 November 2020. In addition to EU coun- partner “BioNTech”, has been registered first in the EU. Phase III - ceutical company Sinovac Biotech, which has shown controversial tries, the vaccine is used in Australia, Saudi Arabia, Switzerland, “CoronaVac” is an inactivated vaccine from Chinese biopharma - Norway, Iceland, Serbia and some other countries.
    [Show full text]
  • The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia's Vaccine
    Article The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia’s Vaccine Rollout Slower than That of Other Nations? Elza Mikule 1,*,† , Tuuli Reissaar 1,† , Jennifer Villers 1,† , Alain Simplice Takoupo Penka 1,† , Alexander Temerev 2 and Liudmila Rozanova 2 1 Global Studies Institute, University of Geneva, 1205 Geneva, Switzerland; [email protected] (T.R.); [email protected] (J.V.); [email protected] (A.S.T.P.) 2 Institute of Global Health, University of Geneva, 1202 Geneva, Switzerland; [email protected] (A.T.); [email protected] (L.R.) * Correspondence: [email protected] † These authors contributed equally. Abstract: The emergence of the SARS-CoV-2 pandemic in the beginning of 2020 led to the deployment of enormous amounts of resources by different countries for vaccine development, and the Russian Federation was the first country in the world to approve a COVID-19 vaccine on 11 August 2020. In our research we sought to crystallize why the rollout of Sputnik V has been relatively slow considering that it was the first COVID-19 vaccine approved in the world. We looked at production capacity, at the number of vaccine doses domestically administered and internationally exported, and at vaccine hesitancy levels. By 6 May 2021, more first doses of Sputnik V had been administered Citation: Mikule, E.; Reissaar, T.; abroad than domestically, suggesting that limited production capacity was unlikely to be the main Villers, J.; Takoupo Penka, A.S.; reason behind the slow rollout. What remains unclear, however, is why Russia prioritized vaccine Temerev, A.; Rozanova, L.
    [Show full text]
  • Iran Hopes to Defeat COVID with Home-Grown Crop of Vaccines
    Q&A Iran hopes to defeat COVID with home-grown crop of vaccines Iran is one of few Middle Eastern nations to transfer money is restricted, it is difficult with the capacity to develop vaccines. It to buy drugs and medicines. And we have has been doing so in earnest: more than the technology to produce vaccines, so why ten are in development, but little is known not use it? To ensure the safety of Iranians, it about them outside Iran. Nature speaks makes sense to develop a variety of vaccines to Kayhan Azadmanesh, head of the using different research and development virology division at the Pasteur Institute of strategies, as China has done. Iran in Tehran, about the nation’s vaccine landscape. Azadmanesh also advises the Why are Iranian researchers reluctant to Iranian government and is developing publicize their work internationally? vaccines through his spin-off company This could be another effect of the sanctions. Humimmune Biotech. Researchers in Iran might not want to draw too much attention to their work in case they How badly has the pandemic affected Iran? put potential partnerships in jeopardy or they Since January 2020, we’ve had five waves. run the risk of losing access to raw materials. We’re currently experiencing the highest Researchers are also extremely busy number of new cases reported so far, with during the pandemic. But some have started MAJID ASGARIPOUR/WANA VIA REUTERS MAJID ASGARIPOUR/WANA around 40,000 a day, and the most common to share results. In June, the researchers variant we detect is Delta.
    [Show full text]
  • COVID-19 Vaccines Update Supplement Week Of: 21Sth June, 2021
    CARPHA UPDATE FOR Incident Manager / SITUATION REPORT COVID-19 Vaccines Update Supplement Week of: 21sth June, 2021 I. Overview of Development and Regulatory Approvals: • 102 candidate vaccines are in clinical development: 18 in Phase 3 trials, and 5 in Phase 4 trials – Table 1; Figure in COVID-19 Vaccines and Therapeutics Regulatory Tracker (Phases tab). • 18 vaccines have received regulatory approvals in various countries, and 18 are at various stages of engagement with WHO for emergency use listing (EUL) including vaccines made in Cuba. • 8 vaccines have been approved by WHO for EUL to date: Pfizer-BioNTech’s vaccine: COMIRNATY®, AstraZeneca-SK Bio, AstraZeneca-SII (Covishield), Janssen-Cilag, AstraZeneca (Vaxzevria™), Moderna (mRNA-1273), Sinopharm-BIBP and Sinovac COVID-19 vaccine – CoronaVac: Table 4. • COVID-19 vaccine interim recommendations by the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) for reviewed vaccines may be found at: SAGE COVID-19 materials. • CARPHA’s COVID-19 vaccine regulatory tracker provides an overview of profiles and regulatory approvals for various candidate vaccines and therapeutics. This sheet includes information on the efficacy of the vaccines in light of current variants of concern, as per WHO updates. • CARPHA-CRS has recommended 7 COVID-19 vaccines to Member States to date – Table 4. The CRS has started its review of Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac. Table 1: Candidate Vaccines under Clinical evaluation, by type or platform. Platform Description Phase
    [Show full text]
  • Building Visualizations to Uncover Insights in Clinical Trial and Pipeline Data
    Building visualizations to uncover insights in clinical trial and pipeline data: a COVID-19 vaccine case study Matt Eberle, Lead Developer, Analytics and Custom Solutions, BizInt Solutions, Inc. Diane Webb, President and Co-Founder, BizInt Solutions, Inc. Wednesday, March 24, 2021, 2:00 pm ET This session will start momentarily…. Webinar Host Susie Corbett PHT Chair Pharmaceutical & Health Technology Community https://connect.sla.org/pht/home Matt Eberle Lead Developer, Analytics and Custom Solutions, BizInt Solutions, Inc. [email protected] Following over ten years of experience at Wyeth, Pfizer and Sunovion as a Senior Information Scientist and Pharmaceutical Information Analyst, since 2013 Matt has helped BizInt customers use the BizInt Smart Charts and VantagePoint tools to create new solutions to address their challenges and problems. Matt lives outside Boston, MA. Diane Webb President and Co-Founder, BizInt Solutions, Inc. [email protected] Diane has over 30 years of experience managing the development of software tools to analyze and present competitive intelligence information, with a focus on drug pipeline, clinical trial and patent data. In 1996 Diane and John Willmore started BizInt Solutions to develop and market the BizInt Smart Charts product family. Diane & John live near Seattle, WA, with their current pack of four longhaired dachshunds. Building visualizations to uncover insights in clinical trial and pipeline data: a COVID-19 vaccine case study Part I: Dashboard visualizations and initial challenges PHT Pharma
    [Show full text]
  • The Covid–19 Pandemic and Haemglobin Isorders
    THE COVID–19 PANDEMIC AND HAEMGLOBIN ISORDERS UPDATE: 29 June 2021 Vaccinations “Immunization is a key component of primary health care and an indisputable human right. It is also one of the best health investments money can buy. Vaccines are thus critical to the prevention and control of infectious-disease outbreaks. They underpin global health security and will be a vital tool in the battle against antimicrobial resistance”. – WHO https://www.who.int/health- topics/vaccines-and- immunization “Since the beginning of the pandemic, WHO has taken steps to prevent an “infodemic”— defined by the organization as “an overabundance of information and the rapid spread of misleading or fabricated news, images, and videos.” WHO and the Wikimedia Foundation, the nonprofit organization that administers Wikipedia, have established a collaboration to expand the public’s access to the latest and most reliable information about COVID-19”. Information about the initiative is available at: https://www.who.int/news/item/22-10- 2020- the-world-health-organization-and-wikimedia-foundation-expand-access-to- trusted- information-aboutcovid-19-on-wikipedia TIF shares the concerns of false information and misleading overabundance of information. This often happens in the effort to enhance hope to a population that is suffering not only from the disease itself, but also from its economic future, since lockdown/isolation practices are stifling the market economies of every country around the world. Hope however, must be based on realistic expectations and information. For these reasons, TIF updates on new developments concerning vaccinations and new therapies are scanned for accuracy and are reviewed now more regularly.
    [Show full text]